All Episodes
ASTCT Talks — 85 episodes
Is Less More? Antibiotic De-escalation in Hematopoietic Cell Transplants
Taking CAR T Outpatient: A Clinical Pharmacy Perspective
TIL Therapy in Sarcoma: From Tumor Procurement to Clinical Response
Understanding Immune Effector Cell-Associated Enterocolitis After CAR T-Cell Therapy
Exploring CAR T Updates in Pediatric Acute Lymphoblastic Leukemia
Titans of Transplant Featuring Dr. Crystal Mackall
The Role of the Social Worker in CAR T Care
TIL Therapy for Solid Tumors
Titans of Transplant: Catherine Bollard, MBChB, MD
Navigating the Dynamic Landscape of Stem Cell Transplantation
GVHD in Pediatrics: Acute and Chronic Risk
Unraveling Key Hematologic Oncology Developments at ASCO 2026
Exploring and Managing Gastrointestinal-Related CAR T-Cell Lymphomas
ASTCT Talks: Gene Therapy Today and Tomorrow
Treatment Options for cGVHD: Adult vs. Pediatric Perspectives
Best Practice Considerations for Infection Prevention and Management Post-CAR T
LIVE From ASH: Multiple Myeloma Treatment Redefined by Bispecific Antibodies and T-Cell Therapies
What Clinicians Need to Know About Chronic GVHD and Immunity
Pulmonary Manifestations of Chronic GVHD
Tackling Cognitive Challenges in Survivorship Care
Titans of Transplant: Innovations in CAR T Cell Therapy
Pharmacist Takeover: BCMA Bispecifics and CAR T-Cell Therapy
Optimizing Care for TILs, Cellular Therapy in Melanoma and Solid Tumors
Cord Blood Transplantation: Past, Present and Future Innovations
Managing Mental Health in Chronic GVHD
Physician-Patient Communication in the Post-Transplant Setting
Delayed Neurotoxicity With Car-T Therapy in Myeloma: What Clinicians Need To Know
Titans of Transplant: Dr. Daniel Weisdorf
CAR T and Transplantation Advances Across Hematologic Cancers at ASCO 2025
Homegrown CAR-T: Expanding Access Through Academic Innovation
Rethinking Tacrolimus Targets in the PTCy Era
Reviewing Real-World Use of Beti-Cel in Transfusion-Dependent β-Thalassemia
Key CAR T and Transplantation Presentations From The 2025 Tandem Meeting
Understanding Cutaneous GVHD: Clinical Insights and Care Strategies
The Role of Lifestyle Medicine in Chronic GVHD with Dr. Steven Pavletic
Optimizing Graft Selection: A New Era in Transplantation with Dr. Lori Muffly
EOral Chronic Graft-Versus-Host Disease and Oral Health After Allogeneic Hematopoietic Cell Transplantation — What the Care Team Needs To Know
Titans of Transplant: Dr. Renier Brentjens
Understanding Ocular Graft-versus-Host Disease to Facilitate an Integrated Multidisciplinary Approach
Leveraging Ex Vivo Gene Therapy Advancements in Hemoglobinopathies and Metabolic Diseases
Outpatient CAR T: Navigating Logistics and Patient Care
Bridging the Gap: Addressing Disparities in GVHD Care
Managing Secondary Cancer Risks After CAR T-Cell Therapy in Multiple Myeloma Subgroups
Exploring Insights From CAR-TITUDE 4 and KarMMa-3 Trials with Dr. Jens Hillengass
A New Era in GVHD Prophylaxis: A Conversation With Dr. Samer Al-Homsi
Beyond Remission: Navigating the Late Effects of Pediatric CAR T-Cell Therapy
A Conversation with Mike Niles: Author of ‘Hard Graft: Our Fight Against Killer Blood’
Titans of Transplant: Dr. Stephanie Lee
Exploring the BMT CTN 1703 Study
Navigating CAR-T Survivorship
Beyond BCMA: Exploring Talquetamab in Myeloma Therapy
Behind the Scenes of CAR-T Therapy at University of California, Davis
Revitalizar, Prosperar y Sobrevivir: El Poder del Movimiento en la Recuperación de los Trasplantes
Revitalize, Thrive, and Survive: The Power of Movement in Transplant Recovery
A PTCy of Relief: GVHD Prophylaxis in Matched Unrelated Donors
Navigating Intersectionality in GVHD and Transplant Medicine
Advancing ALL Treatment and Insights on MRD Monitoring
Monitoring After CAR-T Therapy for Multiple Myeloma: The APP Perspective
Titans of Transplant: Dr. Rick Jones
Breaking Barriers and Dispelling Misconceptions in Transplantation
How to Handle CAR-T Waitlists in Multiple Myeloma
Treating Cytopenias After CAR T-cell Therapy
Bispecific Antibodies in Myeloma: The Who, What, When, and Where
Virus-Specific T-Cells (VST): Where We Are and How We Got Here
Titans of Transplant: Dr. Micah Skeens
MRD in Relation to Transplantation and Cell Therapy
The Winter "Tridemic" in Cellular Therapy
Titans of Transplant: Susan Slater, MN, FNP-BC
Monkeypox in HCT and CAR T
Titans of Transplant: Dr. John F. DiPersio
Celebrating Advocacy Efforts, Overcoming Barriers and Addressing Inequity in Cellular Transplantation
Titans of Transplant: Dr. Rainer Storb
Titans of Transplant: Dr. Adriana Seber
Finding Affordable and Accessible Hematopoietic Cell Transplants
Titans of Transplant: Dr. Krishna Komanduri
Managing COVID-19 in Transplant Patients
Titans of Transplant: Dr. Gregorio Jaimovich
Titans of Transplant: Dr. Mary Horowitz
A Deep Dive On Early Time-to-Toci
Advancements in Immunotherapies with Dr. DiPersio
Outpatient Haploidentical Stem Cell Transplantation
A Deep Dive on Chronic GVHD
The Role of MRD in Multiple Myeloma
MRD Negativity and Lenalidomide Maintenance Therapy: The Possible Next Chapter in Multiple Myeloma Care
Dr. Lia Gore Discusses Bispecific T-Cell Engagers in Pediatric ALL Research